Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia.
about
The physiology of cardiovascular disease and innovative liposomal platforms for therapyTrans-Stent B-Mode Ultrasound and Passive Cavitation Imaging.Stability of echogenic liposomes as a blood pool ultrasound contrast agent in a physiologic flow phantom.Nitric Oxide-Enhanced Molecular Imaging of Atheroma using Vascular Cellular Adhesion Molecule 1-Targeted Echogenic Immunoliposomes.Loss of echogenicity and onset of cavitation from echogenic liposomes: pulse repetition frequency independence.Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery.Nitric oxide pretreatment enhances atheroma component highlighting in vivo with intercellular adhesion molecule-1-targeted echogenic liposomes.Cavitation thresholds of contrast agents in an in vitro human clot model exposed to 120-kHz ultrasound.Nitric oxide improves molecular imaging of inflammatory atheroma using targeted echogenic immunoliposomes.Pulsed ultrasound enhances the delivery of nitric oxide from bubble liposomes to ex vivo porcine carotid tissue.Relationship between cavitation and loss of echogenicity from ultrasound contrast agents.Ultrasound-mediated drug delivery for cardiovascular disease.In vitro measurement of attenuation and nonlinear scattering from echogenic liposomes.Nitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage.Passive imaging with pulsed ultrasound insonations.Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles.Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter.In vivo therapeutic gas delivery for neuroprotection with echogenic liposomes.Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeuticsCardiovascular therapeutic uses of targeted ultrasound contrast agents.Nanocarriers for nitric oxide delivery.Nitric oxide-releasing poly(lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activity.Nitric oxide release: part I. Macromolecular scaffoldsNitric oxide release: part II. Therapeutic applications.Liposome technology for cardiovascular disease treatment and diagnosis.Nitric oxide in paediatric respiratory disorders: novel interventions to address associated vascular phenomena?Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO).Nitric oxide generating/releasing materials.Nitric oxide as a surgical adjuvant.Lipid-based carriers for controlled delivery of nitric oxide.An unmet clinical need: The history of thrombus imaging.MRI-guided and ultrasound-triggered release of NO by advanced nanomedicine.Liposome-Loaded Cell Backpacks.
P2860
Q27002949-702BCED0-0B3F-4FA7-B71D-C7ACED02C15DQ30364821-F66CBF70-90B8-43A8-8C24-84D27CFB7149Q30380934-C30CEB48-2647-40C1-B923-C337AB287D22Q30382612-DAAAA0E2-4A71-4D85-AE56-2C0841284E5BQ30395085-A2EC4106-AA33-45CB-8AD9-49C0DA9ED0CDQ30409097-5EAF021D-F04B-4377-9684-BE63A0E66B95Q30410620-8082E45D-352A-44A5-93B3-BC3E342E78AEQ30419740-D244C5D2-9481-4BA2-B6B5-442438EFA094Q30423822-C43FA759-7B22-48E9-B448-FCD29C34E091Q30428065-19149488-F82A-41D4-8600-0CCEA0A976BEQ30430439-0F200940-D5C6-4E01-B45E-FEA4AA5C4A10Q30438336-D0C9D0FB-1C03-41CC-B203-D9FB3C5CC004Q30444512-4C2C9C97-1775-4FE1-93EF-35D26BD8271EQ30445314-CD2E6333-EE3F-4C26-B344-815012540259Q30452908-0833721A-142A-4AAD-A8EE-F416BB422FE7Q30454594-11FC7F75-545C-41E0-A1DF-D178691FB0DDQ30461828-7CAF5A7F-E1D4-42A4-B140-203A20F51F4CQ30473667-F9315B7A-5EE3-4DED-B5D4-B51DB32C48BBQ30476296-268574D8-D5C6-4F40-ADFE-21E02C8F2B50Q30479697-C536EAF5-FAA0-4C81-BAE2-602E374355F6Q35176430-9F401258-FE88-4500-ACAC-53BA124226AFQ35542339-61E3CFDF-DF4C-43F7-8805-79B6841CDF79Q35926045-1548C04C-5182-4013-A359-39263D007E8BQ35926097-9D2E015D-7615-471B-ABB5-223DB68ACA94Q37974931-B708EC80-017F-46BB-8E7D-8D4D0F9FBD32Q38842183-E9A6EFAD-3738-41FD-A0DF-88B1330B8C43Q38844542-AD3B1587-D56D-469A-9299-D0A38022262DQ38910851-37D193B2-5CAF-421D-A164-A2AF2F195133Q38979827-1470588D-D388-4162-A7A7-00C92BE22E60Q39100762-C07C8BF5-E504-4C51-83AE-33B147ABB4D2Q47177380-F5D9FA8B-4084-4975-AC4F-4E92831D0E74Q48181056-70437F4B-772F-479C-802F-744F1AD6566DQ51625765-8FBDF3DF-8660-4089-A9EE-6B2861E701C9
P2860
Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nitric oxide-loaded echogenic ...... bition of intimal hyperplasia.
@ast
Nitric oxide-loaded echogenic ...... bition of intimal hyperplasia.
@en
type
label
Nitric oxide-loaded echogenic ...... bition of intimal hyperplasia.
@ast
Nitric oxide-loaded echogenic ...... bition of intimal hyperplasia.
@en
prefLabel
Nitric oxide-loaded echogenic ...... bition of intimal hyperplasia.
@ast
Nitric oxide-loaded echogenic ...... bition of intimal hyperplasia.
@en
P2093
P2860
P1476
Nitric oxide-loaded echogenic ...... bition of intimal hyperplasia.
@en
P2093
David D McPherson
Hyunggun Kim
Melanie R Moody
Patrick H Kee
Robert C Macdonald
Shao-Ling Huang
Stephen M Chrzanowski
P2860
P304
P356
10.1016/J.JACC.2009.04.039
P407
P577
2009-08-01T00:00:00Z